Видео ютуба по тегу Medicines: Mitapivat

SATISFY: mitapivat in patients with erythrocyte membranopathies
SATISFY: mitapivat in patients with erythrocyte membranopathies
Advances in pyruvate kinase activators for MDS and PKD: mitapivat & AG946
Advances in pyruvate kinase activators for MDS and PKD: mitapivat & AG946
Mitapivat in SCD: one-year follow-up results from the ESTIMATE trial
Mitapivat in SCD: one-year follow-up results from the ESTIMATE trial
What you NEED to know about MOA of PYRUKYND (mitapivat) -- approved for PK Deficiency Anemia
What you NEED to know about MOA of PYRUKYND (mitapivat) -- approved for PK Deficiency Anemia
Hanny Al-Samkari: Mitapivat for Patients With Pyruvate Kinase Deficiency
Hanny Al-Samkari: Mitapivat for Patients With Pyruvate Kinase Deficiency
Mitapivat improves work/school attendance in patients with pyruvate kinase deficiency
Mitapivat improves work/school attendance in patients with pyruvate kinase deficiency
Insights into the mechanism of action and applications of mitapivat
Insights into the mechanism of action and applications of mitapivat
Agios CEO Jackie Fouse on FDA Orphan Drug Designated Mitapivat
Agios CEO Jackie Fouse on FDA Orphan Drug Designated Mitapivat
Mechanism of action of mitapivat and its potential in the treatment of SCD
Mechanism of action of mitapivat and its potential in the treatment of SCD
The promise of pyruvate kinase activators, such as mitapivat, for treating SCD and thalassemia
The promise of pyruvate kinase activators, such as mitapivat, for treating SCD and thalassemia
MedX Episode 3: the Latest from World of Medicine
MedX Episode 3: the Latest from World of Medicine
The potential of mitapivat and other pyruvate kinase activators in SCD
The potential of mitapivat and other pyruvate kinase activators in SCD
Updates from the ENERGIZE study of mitapivat in non-transfusion-dependent alpha-/beta-thalassemia
Updates from the ENERGIZE study of mitapivat in non-transfusion-dependent alpha-/beta-thalassemia
Mitapivat increases β-thalassemic erythroblast energy production and oxidative stress responsiveness
Mitapivat increases β-thalassemic erythroblast energy production and oxidative stress responsiveness
The impact of luspatercept and mitapivat on transfusion dependence in patients with thalassemia
The impact of luspatercept and mitapivat on transfusion dependence in patients with thalassemia
Update on the ENERGIZE trial of mitapivat in NTD alpha- and beta-thalassemia
Update on the ENERGIZE trial of mitapivat in NTD alpha- and beta-thalassemia
Precision Medicine in Rare Hematological Diseases: Pyruvate Kinase Activators
Precision Medicine in Rare Hematological Diseases: Pyruvate Kinase Activators
Thrive Conference Series: Science Supporting PK-Activators and Related Research Update
Thrive Conference Series: Science Supporting PK-Activators and Related Research Update